CareView Narrows Q3 Loss by 33% on Strong Software Sales, Revenue Up 9%

TL;DR

**CRVW is still a high-risk bet, but the shrinking loss and revenue growth offer a glimmer of hope for speculative traders.**

AI Summary

CareView Communications Inc. reported a significant reduction in net loss for the nine months ended September 30, 2025, decreasing to $2,423,724 from $3,600,152 in the prior year, representing a 32.7% improvement. Total revenues increased by 9.4% to $6,682,928 for the nine months ended September 30, 2025, up from $6,109,259 in the same period of 2024. This growth was primarily driven by a 29.3% increase in sales-based software bundle revenue, reaching $2,941,382, and a 20.5% increase in total sales-based revenue to $3,725,638. Operating expenses saw a 8.1% decrease, falling to $6,751,334 from $7,346,174, largely due to reduced network operations and general and administration costs. Despite these improvements, the company continues to operate with a substantial accumulated deficit of $215,009,822 as of September 30, 2025, and current liabilities of $46,309,812, including $20,000,000 in notes payable and $22,094,014 in accrued interest payable, significantly exceeding its total assets of $4,977,571. Cash increased to $1,731,276 from $759,266 at December 31, 2024, primarily from operating activities.

Why It Matters

CareView's ability to significantly reduce its net loss and grow revenue, particularly in software bundles, suggests potential operational efficiencies and market traction for its healthcare solutions. For investors, the narrowing loss and increased cash from operations are positive signals, but the massive accumulated deficit and high current liabilities, especially the $22 million in accrued interest, remain critical concerns, indicating severe financial distress. Competitively, if CareView can sustain revenue growth and further cut costs, it might carve out a niche in the patient monitoring market, but its financial structure makes it vulnerable. Employees and customers might see more stability if the company continues this positive operational trend, but the long-term viability is still questionable given the debt burden.

Risk Assessment

Risk Level: high — CareView Communications Inc. faces a high risk level due to its substantial accumulated deficit of $215,009,822 as of September 30, 2025, and total liabilities of $47,369,261 far exceeding its total assets of $4,977,571. The company also carries $20,000,000 in notes payable and $22,094,014 in accrued interest payable, indicating a precarious financial position despite operational improvements.

Analyst Insight

Investors should approach CRVW with extreme caution, recognizing the high-risk, high-reward profile. While the reduced net loss and revenue growth are positive, the overwhelming debt and accumulated deficit demand a deep dive into the company's ability to service its liabilities. Consider this a highly speculative play, suitable only for those with a high-risk tolerance and a clear understanding of the significant downside potential.

Financial Highlights

debt To Equity

N/A

revenue

$6,682,928

operating Margin

N/A

total Assets

$4,977,571

total Debt

$47,369,261

net Income

-$2,423,724

eps

N/A

gross Margin

N/A

cash Position

$1,731,276

revenue Growth

+9.4%

Revenue Breakdown

Key Numbers

• $2.42M — Net Loss (Decreased by 32.7% for the nine months ended September 30, 2025, from $3.60M in 2024.)
• $6.68M — Total Revenues (Increased by 9.4% for the nine months ended September 30, 2025, from $6.11M in 2024.)
• $2.94M — Sales-based Software Bundle Revenue (Increased by 29.3% for the nine months ended September 30, 2025, from $2.28M in 2024.)
• $215.01M — Accumulated Deficit (As of September 30, 2025, indicating significant historical losses.)
• $42.39M — Total Stockholders' Deficit (As of September 30, 2025, worsening from $40.43M at December 31, 2024.)
• $20.00M — Notes Payable (Unchanged from December 31, 2024, representing a significant current liability.)
• $22.09M — Accrued Interest Payable (Increased from $19.69M at December 31, 2024, highlighting growing debt burden.)
• $1.73M — Cash (Increased from $759,266 at December 31, 2024, primarily from operating activities.)
• $4.98M — Total Assets (As of September 30, 2025, significantly less than total liabilities.)
• $47.37M — Total Liabilities (As of September 30, 2025, indicating a highly leveraged position.)

Key Players & Entities

• CareView Communications Inc. (company) — Registrant
• SEC (regulator) — Securities and Exchange Commission
• $2,423,724 (dollar_amount) — Net loss for nine months ended September 30, 2025
• $3,600,152 (dollar_amount) — Net loss for nine months ended September 30, 2024
• $6,682,928 (dollar_amount) — Total revenues for nine months ended September 30, 2025
• $6,109,259 (dollar_amount) — Total revenues for nine months ended September 30, 2024
• $2,941,382 (dollar_amount) — Sales-based software bundle revenue for nine months ended September 30, 2025
• $215,009,822 (dollar_amount) — Accumulated deficit as of September 30, 2025
• $20,000,000 (dollar_amount) — Notes payable as of September 30, 2025
• $22,094,014 (dollar_amount) — Accrued interest payable as of September 30, 2025

FAQ

Risk Factors

• Substantial Accumulated Deficit and Negative Stockholders' Equity [high — financial]: As of September 30, 2025, CareView has an accumulated deficit of $215,009,822 and a total stockholders' deficit of $42,391,690. This indicates a history of significant losses and a precarious financial position, with total liabilities ($47,369,261) far exceeding total assets ($4,977,571).
• High Leverage and Significant Debt Obligations [high — financial]: The company carries substantial liabilities, including $20,000,000 in notes payable and $22,094,014 in accrued interest payable as of September 30, 2025. Total liabilities of $47,369,261 significantly outweigh total assets of $4,977,571, indicating a highly leveraged and potentially unsustainable capital structure.
• Dependence on Sales-Based Software Bundle Growth [medium — operational]: While sales-based software bundle revenue grew by 29.3% to $2,941,382 for the nine months ended September 30, 2025, the company's overall financial health relies heavily on the continued success and growth of this segment. Any slowdown could negatively impact revenue and profitability.
• Declining Subscription and Equipment Revenue [medium — operational]: Subscription-based revenue decreased by 1.97% and sales-based equipment package revenue decreased by 3.99% for the nine months ended September 30, 2025. This trend, if it continues, could offset growth in other areas and impact overall revenue stability.
• Negative Working Capital Position [high — financial]: As of September 30, 2025, total current liabilities ($46,309,812) far exceed total current assets ($3,520,159), resulting in a significant negative working capital. This suggests potential short-term liquidity challenges.

Industry Context

CareView Communications operates in the healthcare technology sector, specifically focusing on remote patient monitoring and communication solutions. The industry is characterized by increasing demand for telehealth services, driven by an aging population and the need for cost-effective healthcare delivery. However, it also faces competition from established players and emerging startups, alongside evolving regulatory landscapes and data security concerns.

Regulatory Implications

The company must adhere to stringent healthcare regulations such as HIPAA, ensuring the privacy and security of patient data. Any breaches or non-compliance could lead to significant fines and reputational damage. Changes in reimbursement policies for remote patient monitoring services could also impact revenue streams.

What Investors Should Do

1. Monitor debt reduction and cash flow generation
2. Analyze sustainability of sales-based software bundle growth
3. Evaluate the company's path to profitability

Key Dates

• 2025-09-30: Nine Months Ended — Reported a 9.4% increase in total revenues to $6,682,928 and a 32.7% reduction in net loss to $2,423,724, indicating operational improvements.
• 2025-09-30: Balance Sheet Date — Total assets were $4,977,571, while total liabilities stood at $47,369,261, highlighting a significant negative equity position and high leverage.
• 2024-12-31: Prior Year End — Cash position was $759,266, and total liabilities were $44,055,854, showing an increase in cash but also a rise in total liabilities.

Glossary

Accumulated deficit

The cumulative net losses of a company that have not been offset by net income in prior periods. (Indicates the company's long-term profitability challenges, with a substantial deficit of $215,009,822 as of September 30, 2025.)

Stockholders' deficit

Occurs when a company's liabilities exceed its assets, resulting in a negative net worth for shareholders. (CareView has a stockholders' deficit of $42,391,690 as of September 30, 2025, underscoring its negative equity position.)

Sales-based software bundle revenue

Revenue generated from selling software packages that are tied to sales performance or volume. (This segment showed strong growth of 29.3% to $2,941,382 for the nine months ended September 30, 2025, and is a key driver of the company's top-line increase.)

Accrued interest payable

Interest expense that has been incurred but not yet paid. (This liability increased to $22,094,014 as of September 30, 2025, reflecting a growing debt burden and the cost of servicing its debt.)

Deferred revenue

Revenue that has been received by a company for goods or services that have not yet been delivered or rendered. (Deferred revenue increased to $2,778,973 (current) and $303,432 (non-current) as of September 30, 2025, suggesting future revenue streams from unfulfilled obligations.)

Year-Over-Year Comparison

Compared to the prior year, CareView Communications has shown positive momentum in revenue growth, with total revenues increasing by 9.4% to $6,682,928 for the nine months ended September 30, 2025. The net loss also decreased by 32.7% to $2,423,724. However, the company's financial structure remains highly leveraged, with total liabilities of $47,369,261 significantly exceeding total assets of $4,977,571, and the accumulated deficit remains substantial at $215,009,822.

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value per share CRVW OTC Markets

Filing Documents

• crvw20250930_10q.htm (10-Q) — 1033KB
• ex_855773.htm (EX-31.1) — 13KB
• ex_855774.htm (EX-31.2) — 13KB
• ex_855775.htm (EX-32) — 5KB
• crvw20240331_10qimg001.jpg (GRAPHIC) — 3KB
• 0001437749-25-034523.txt ( ) — 5375KB
• crvw-20250930.xsd (EX-101.SCH) — 50KB
• crvw-20250930_cal.xml (EX-101.CAL) — 44KB
• crvw-20250930_def.xml (EX-101.DEF) — 278KB
• crvw-20250930_lab.xml (EX-101.LAB) — 256KB
• crvw-20250930_pre.xml (EX-101.PRE) — 315KB
• crvw20250930_10q_htm.xml (XML) — 970KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item. 1

Financial Statements

Financial Statements Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024 3 Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 (Unaudited) 4 Condensed Consolidated Statements of Changes in Stockholders' Deficit for the Three and Nine Months Ended September 30, 2025 and 2024 (Unaudited) 5 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 (Unaudited) 6 Notes to the Condensed Consolidated Financial Statements 7 Item 2. Management ' s Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 24 Item 4.

Controls and Procedures

Controls and Procedures 24

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 26 Item 1A.

Risk Factors

Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26 Item 3. Defaults Upon Senior Securities 26 Item 4. Mine Safety Disclosures 26 Item 5. Other Information 26 Item 6. Exhibits 26 Table of Contents CAREVIEW COMMUNICATIONS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2025 December 31, (unaudited) 2024 ASSETS Current Assets: Cash $ 1,731,276 $ 759,266 Accounts receivable 1,048,596 1,000,706 Inventory 425,615 418,131 Other current assets 314,672 484,256 Total current assets 3,520,159 2,662,359 Property and equipment, net 113,519 176,103 Other Assets: Intangible assets, net 366,435 397,380 Operating lease right-of-use asset 778,221 126,876 Other assets, net 199,237 258,869 Total other assets 1,343,893 783,125 Total assets $ 4,977,571 $ 3,621,587 LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities: Accounts payable $ 254,099 470,162 Notes payable 20,000,000 20,000,000 Notes payable - related parties 700,000 700,000 Deferred revenue 2,778,973 2,413,771 Operating lease liability 46,466 142,573 Accrued interest payable 22,094,014 19,687,639 Other current liabilities 436,260 387,081 Total current liabilities 46,309,812 43,801,226 Long-term Liabilities: Operating lease liability, non-current 747,432 - Deferred revenue 303,432 254,628 Other liabilities 8,585 - Total long-term liabilities 1,059,449 254,628 Total liabilities 47,369,261 44,055,854 Stockholders' Deficit: Preferred stock - par value $ 0.001 ; 20,000,000 shares authorized; no shares issued and outstanding - - Common stock - par value $ 0.001 ; 800,000,000 shares authorized; 583,880,748 issued and outstanding 583,881 583,881 Additional paid in capital 172,034,251 171,567,950 Accumulated deficit ( 215,009,822 ) ( 212,586,098 ) Total stockholders' deficit ( 42,391,690 ) ( 40,434,267 ) Total liabilities and st

View Full Filing

View this 10-Q filing on SEC EDGAR